50 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27977181	8	An Orally Active Bradykinin B	Nanyang Technological University
23403082	28	Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.	Broad Institute of Mit and Harvard
22369198	40	From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.	Laboratoires Fournier
22342268	98	Design and synthesis of novel sulfonamide-containing bradykinin hB(2) receptor antagonists. Synthesis and structure-relationships ofa,a-tetrahydropyranylglycine.	Menarini Ricerche
8691478	25	Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.	Cortech
21413808	170	Synopsis of some recent tactical application of bioisosteres in drug design.	Bristol-Myers Squibb Pharmaceutical Research and Development
21571530	62	Discovery of a potent and selective small molecule hGPR91 antagonist.	Advinus Therapeutics
22483585	28	Quinolinyl- and phenantridinyl-acetamides as bradykinin B1 receptor antagonists.	Gedeon Richter
18553956	38	2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.	Merck Research Laboratories
18240388	19	A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity.	Merck Research Laboratories
18061443	34	Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonists.	Merck Research Laboratories
12723943	29	Benzodiazepines as potent and selective bradykinin B1 antagonists.	Merck Research Laboratories
10514288	12	Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety.	University of Montpellier
22197141	64	Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency.	Amgen
22088753	44	Chromenones as potent bradykinin B1 antagonists.	Amgen
21902230	49	Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.	Amgen
21615150	14	Progress in structure based drug design for G protein-coupled receptors.	Heptares Therapeutics
21514825	81	3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation.	Amgen
20369879	21	Bradykinin B1 receptor antagonists as potential therapeutic agents for pain.	Johnson & Johnson Pharmaceutical Research and Development
20813948	63	Spiroindolones, a potent compound class for the treatment of malaria.	Swiss Tropical and Public Health Institute
20573508	31	Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists.	Amgen
20036120	16	Novel small molecule bradykinin B1 receptor antagonists. Part 3: hydroxyurea derivatives.	Jerini
20015651	16	Novel small molecule bradykinin B1 receptor antagonists. Part 2: 5-membered diaminoheterocycles.	Jerini
20015645	24	Novel small molecule bradykinin B1 receptor antagonists. Part 1: benzamides and semicarbazides.	Jerini
19014884	18	Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists.	Pharmacopeia
18752949	60	1-Benzylbenzimidazoles: the discovery of a novel series of bradykinin B(1) receptor antagonists.	Neurogen
18722115	11	Bradykinin B1 receptor antagonists: an alpha-hydroxy amide with an improved metabolism profile.	Merck
18706809	45	Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.	Amgen
18674903	32	Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists.	Amgen
18068274	2	Novel bradykinin-1 antagonists containing a (1,2,3,4-tetrahydro-isoquinolin-1-yl)acetic acid scaffold.	University of Szeged
17880055	42	Preparation and optimization of a series of 3-carboxamido-5-phenacylaminopyrazole bradykinin B1 receptor antagonists.	Elan Pharmaceuticals
17482459	17	Bradykinin B1 antagonists: biphenyl SAR studies in the cyclopropanecarboxamide series.	Merck
17428657	18	Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.	Merck
17408249	76	Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.	Amgen
17243660	42	Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity.	Amgen
17228869	44	Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.	Merck Research Laboratories
16529929	55	5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists.	Merck Research Laboratories
16480259	22	Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists.	TBA
16464576	56	A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.	Amgen
15993596	23	Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series.	Merck
15837330	16	2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists.	Merck Research Laboratories
15588075	33	2,3-diaminopyridine bradykinin B1 receptor antagonists.	Merck Research Laboratories
15546726	22	Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies.	Merck Research Laboratories
15341478	13	Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide core.	TBA
10882365	4	A rational approach to the design and synthesis of a new bradykinin B(1) receptor antagonist.	University of Montpellier
10882364	19	Synthesis and biological evaluation of bradykinin B(1)/B(2) and selective B(1) receptor antagonists.	University of Montpellier
26469307	7	Phosphorylation of Capsaicinoid Derivatives Provides Highly Potent and Selective Inhibitors of the Transcription Factor STAT5b.	University of Leipzig